Clinical Proof of Concept of OVX836, a single-shot broadly protective Influenza A vaccine for immediate protection against emerging pandemic strains
75A50125C00008 · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) solicitation, performed in Paris 8. AwardCast estimates what this specific solicitation will close for, before you bid.
Comparable recent awards in RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
| Winner | Award value | Offers | Date |
|---|---|---|---|
| AMERICAN TYPE CULTURE COLLECTION | $4.3M | n/a | 2026-07-01 |
| REGENTS OF THE UNIVERSITY OF MICHIGAN | $17.5M | n/a | 2026-06-30 |
| MICRON BIOMEDICAL INC | $4.5M | 18 | 2026-06-24 |
| TWIST BIOSCIENCE CORPORATION | $47K | 1 | 2026-06-24 |
| CHROMOLOGIC LLC | $4.5M | 18 | 2026-06-24 |
Questions
What is solicitation 75A50125C00008?
Clinical Proof of Concept of OVX836, a single-shot broadly protective Influenza A vaccine for immediate protection against emerging pandemic strains, issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF, under NAICS 541714 (RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)), performed in Paris 8.
What do similar contracts close for?
Comparable closed awards in this category ran from $47K to $17.5M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Is 75A50125C00008 set aside?
NONE. Check the notice on SAM.gov for the eligibility language that governs.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.